Rituximab for the Treatment of Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukaemia

ISSN： 0012-6667

Source： Drugs, Vol.70, Iss.3, 2010-02, pp. : 261-272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab: A Review of its Use in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukaemia

By Plosker G.L. Figgitt D.P.

Drugs, Vol. 63, Iss. 8, 2003-01 ,pp. : 803-843

Adis International

Access to resources Recommend Favorite

Rituximab: A Review of its Use in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukaemia

By Cvetković Risto S. Perry Caroline M.

Drugs, Vol. 66, Iss. 6, 2006-01 ,pp. : 791-820

Adis International

Access to resources Recommend Favorite

Bendamustine: A Review of its Use in the Management of Chronic Lymphocytic Leukaemia, Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma and Multiple Myeloma

By Hoy Sheridan M.

Drugs, Vol. 72, Iss. 14, 2012-10 ,pp. : 1929-1950

Adis International

Access to resources Recommend Favorite

Rituximab: A Review of its Use in Chronic Lymphocytic Leukaemia, Low-Grade or Follicular Lymphoma and Diffuse Large B-Cell Lymphoma

By Keating Gillian M.

Drugs, Vol. 70, Iss. 11, 2010-07 ,pp. : 1445-1476

Adis International

Access to resources Recommend Favorite

Rituximab added to CHOP chemotherapy shows promise as a treatment for HIV-associated non-Hodgkin's lymphoma (NHL)

Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite